In ₹ Crore except Per Share Latest Annual | ORTINGLOBE FY26 | LASA FY26 | MANGALAM FY26 | BIOFILCHEM FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | — | — | — | 21.05× | 21.05× | |
| P/B | 10.72× | 0.69× | ◆ 0.54× | 2.72× | 0.69× +1457% | |
| EV/EBITDA | ◆ -13.19× | -1.54× | -10.74× | 94.77× | -1.54× -759% | |
| Market Cap | ₹13.3 Cr | ₹34.2 Cr | ₹55.2 Cr | ₹58.6 Cr | ₹55.2 Cr -76% | |
| Growth | ||||||
| Revenue CAGR 3Y | -74.44% | -42.11% | — | ◆ -1.85% | -21.98% -239% | |
| Revenue CAGR 5Y | -58.50% | -34.11% | — | ◆ -4.50% | -19.30% -203% | |
| Net Income CAGR 3Y | — | — | — | 70.67% | 70.67% | |
| Revenue YoY (latest Q) | -70.85% | -93.87% | -0.40% | ◆ 91.99% | -0.40% -17612% | |
| Net Income YoY (latest Q) | -92.65% | ◆ 83.05% | 44.64% | -95.47% | 44.64% -308% | |
| Profitability | ||||||
| EBITDA Margin | -1030.05% | -112.98% | -6.42% | ◆ 2.29% | -6.42% -15944% | |
| Net Income Margin | -736.72% | -135.60% | -19.13% | ◆ 9.81% | -19.13% -3751% | |
| Return on Common Equity | -59.85% | -68.70% | -43.08% | ◆ 12.92% | -43.08% -39% | |
| Return on Capital Employed | -46.19% | -69.54% | -27.98% | ◆ 1.70% | -27.98% -65% | |
| Return on Assets | -15.93% | -51.44% | -14.10% | ◆ 6.50% | -14.10% -13% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.81× | 0.20× | 1.02× | ◆ 0.14× | 0.20× +305% | |
| Interest Coverage | -470.77× | -89.13× | -2.04× | ◆ 37.37× | -2.04× -22977% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹0.1 Cr | ₹25.1 Cr | ₹232 Cr | ₹28.4 Cr | ₹28.4 Cr -100% | |
| Net Income | −₹0.7 Cr | −₹34.1 Cr | −₹44.4 Cr | ₹2.8 Cr | −₹34.1 Cr +98% | |
| Total Assets | ₹4.6 Cr | ₹66.3 Cr | ₹315 Cr | ₹42.8 Cr | ₹66.3 Cr -93% | |
| EPS | ₹-0.91 | ₹-6.8 | ₹-28.05 | ₹1.71 | ₹-6.8 +87% | |
| Book Value per Share | ₹1.52 | ₹9.9 | ₹65.11 | ₹13.25 | ₹13.25 -89% | |